A possible synergism of dietary phosphate and urine-acidifying salts in preventing silica urolithiasis in a rat model.
Using an animal model involving rats fed tetraethylorthosilicate, the minimal effective dietary concentration of ammonium chloride for reduction of silica urolithiasis was determined to be approximately 0.10 equivalents/kg diet. Ammonium sulfate appeared to be only slightly less effective. The lower incidences of urolithiasis were associated with urinary pH less than 7. A subprophylactic concentration (0.067 equivalents/kg diet) of ammonium chloride was factored with three levels of supplemental phosphorus (0, 0.15 and 0.30%) from Na2HPO4 to determine whether the antiurolithic effects of dietary phosphate and urinary-acidifying salts are synergistic. Phosphate had no effect on urinary pH. A 50% urolith incidence occurred in controls; the incidence was 25% (P = 0.08) with 0.15 and 10% (P less than 0.01) with 0.30% phosphorus. Urinary pH was 7.5 in controls compared with approximately 7.2 in rats given the subprophylactic level of ammonium chloride, but ammonium chloride alone had no effect on urolithiasis. However, complete protection from urolithiasis was provided by each of the two levels of phosphorus in combination with ammonium chloride. It is concluded that supplemental dietary phosphorus is most effective for protection against silica urolithiasis under conditions contributing toward urinary acidification due to a possible synergism between dietary phosphorus and urinary acidifying salts.
Emerick
R J
RJ
Chemistry Department, South Dakota State University, Brookings 57007.
Lu
D
D
D000643:Ammonium Chloride / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D000645:Ammonium Sulfate / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D004032:Diet; D004195:Disease Models, Animal; D004357:Drug Synergism; D006863:Hydrogen-Ion Concentration; D008297:Male; D010710:Phosphates / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D051381:Rats; D011919:Rats, Inbred Strains; D012821:Silanes; D012822:Silicon Dioxide; D014545:Urinary Calculi / Q000139:chemically induced / Q000517:prevention & control*; D014556:Urine
D010710:Phosphates; D012821:Silanes; D000643:Ammonium Chloride; C040733:tetraethoxysilane; D012822:Silicon Dioxide; D000645:Ammonium Sulfate